Classical pathway activity C3c, C4 and C1-inhibitor protein reference intervals determination in EDTA plasma

INTRODUCTION: Reference intervals (RIs) for complement assays in EDTA plasma samples have not previously been published. The objectives of the present study were to validate and/or determine RIs for classical pathway (CP50) activity and C3c, C4 and C1 inhibitor protein (C1INH) assays and to assess t...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopez, Benjamin, Bertier, Nicolas, Ledoult, Emmanuel, Joudinaud, Romane, Maanaoui, Mehdi, Majerus, Victoria, Moitrot, Emmanuelle, Deleplancque, Anne-Sophie, Rogeau, Stéphanie, Launay, David, Lefèvre, Guillaume, Labalette, Myriam, Dubucquoi, Sylvain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Croatian Society of Medical Biochemistry and Laboratory Medicine 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6784422/
https://www.ncbi.nlm.nih.gov/pubmed/31624460
http://dx.doi.org/10.11613/BM.2019.030707
_version_ 1783457754462027776
author Lopez, Benjamin
Bertier, Nicolas
Ledoult, Emmanuel
Joudinaud, Romane
Maanaoui, Mehdi
Majerus, Victoria
Moitrot, Emmanuelle
Deleplancque, Anne-Sophie
Rogeau, Stéphanie
Launay, David
Lefèvre, Guillaume
Labalette, Myriam
Dubucquoi, Sylvain
author_facet Lopez, Benjamin
Bertier, Nicolas
Ledoult, Emmanuel
Joudinaud, Romane
Maanaoui, Mehdi
Majerus, Victoria
Moitrot, Emmanuelle
Deleplancque, Anne-Sophie
Rogeau, Stéphanie
Launay, David
Lefèvre, Guillaume
Labalette, Myriam
Dubucquoi, Sylvain
author_sort Lopez, Benjamin
collection PubMed
description INTRODUCTION: Reference intervals (RIs) for complement assays in EDTA plasma samples have not previously been published. The objectives of the present study were to validate and/or determine RIs for classical pathway (CP50) activity and C3c, C4 and C1 inhibitor protein (C1INH) assays and to assess the need for age-specific RIs in EDTA plasma. MATERIALS AND METHODS: We retrospectively evaluated a cohort of 387 patients attending our university hospital and known to be free of complement-modifying diseases. The need for age partitioning was assessed and RIs were calculated according to the CLSI protocol. RESULTS: No need for age partitioning was evidenced for CP50 activity, C3c and C4 concentrations and RIs (90% CI) were calculated from the pooled data: 35.4 (33.1-37.2) to 76.3 (73.7-83.6) U/mL for CP50 activity, 0.80 (0.75-0.87) to 1.64 (1.59-1.72) g/L for C3c, and 0.12 (0.10-0.14) to 0.38 (0.36-0.40) g/L for C4. Our results highlight a positive association between age and C1INH concentrations. We derived 3 age partitions (6 months to 30 years, 30-50 and > 50 years) and the related RIs: 0.20 (0.18-0.21) to 0.38 (0.36-0.40) g/L, 0.22 (0.20-0.24) to 0.39 (0.36-0.41) g/L and 0.25 (0.22-0.27) to 0.41 (0.40-0.43) g/L, respectively). CONCLUSIONS: The newly determined RIs for CP50 activity were higher than those provided by the manufacturer for EDTA plasma samples, whereas those for C3c and C4 RIs were similar to the values provided for serum samples. The C1INH concentration and activity were found to be associated with age and age-specific RIs are mandatory for this analyte.
format Online
Article
Text
id pubmed-6784422
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Croatian Society of Medical Biochemistry and Laboratory Medicine
record_format MEDLINE/PubMed
spelling pubmed-67844222019-10-17 Classical pathway activity C3c, C4 and C1-inhibitor protein reference intervals determination in EDTA plasma Lopez, Benjamin Bertier, Nicolas Ledoult, Emmanuel Joudinaud, Romane Maanaoui, Mehdi Majerus, Victoria Moitrot, Emmanuelle Deleplancque, Anne-Sophie Rogeau, Stéphanie Launay, David Lefèvre, Guillaume Labalette, Myriam Dubucquoi, Sylvain Biochem Med (Zagreb) Original Articles INTRODUCTION: Reference intervals (RIs) for complement assays in EDTA plasma samples have not previously been published. The objectives of the present study were to validate and/or determine RIs for classical pathway (CP50) activity and C3c, C4 and C1 inhibitor protein (C1INH) assays and to assess the need for age-specific RIs in EDTA plasma. MATERIALS AND METHODS: We retrospectively evaluated a cohort of 387 patients attending our university hospital and known to be free of complement-modifying diseases. The need for age partitioning was assessed and RIs were calculated according to the CLSI protocol. RESULTS: No need for age partitioning was evidenced for CP50 activity, C3c and C4 concentrations and RIs (90% CI) were calculated from the pooled data: 35.4 (33.1-37.2) to 76.3 (73.7-83.6) U/mL for CP50 activity, 0.80 (0.75-0.87) to 1.64 (1.59-1.72) g/L for C3c, and 0.12 (0.10-0.14) to 0.38 (0.36-0.40) g/L for C4. Our results highlight a positive association between age and C1INH concentrations. We derived 3 age partitions (6 months to 30 years, 30-50 and > 50 years) and the related RIs: 0.20 (0.18-0.21) to 0.38 (0.36-0.40) g/L, 0.22 (0.20-0.24) to 0.39 (0.36-0.41) g/L and 0.25 (0.22-0.27) to 0.41 (0.40-0.43) g/L, respectively). CONCLUSIONS: The newly determined RIs for CP50 activity were higher than those provided by the manufacturer for EDTA plasma samples, whereas those for C3c and C4 RIs were similar to the values provided for serum samples. The C1INH concentration and activity were found to be associated with age and age-specific RIs are mandatory for this analyte. Croatian Society of Medical Biochemistry and Laboratory Medicine 2019-10-15 2019-10-15 /pmc/articles/PMC6784422/ /pubmed/31624460 http://dx.doi.org/10.11613/BM.2019.030707 Text en ©Croatian Society of Medical Biochemistry and Laboratory Medicine. This is an Open Access article distributed under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Lopez, Benjamin
Bertier, Nicolas
Ledoult, Emmanuel
Joudinaud, Romane
Maanaoui, Mehdi
Majerus, Victoria
Moitrot, Emmanuelle
Deleplancque, Anne-Sophie
Rogeau, Stéphanie
Launay, David
Lefèvre, Guillaume
Labalette, Myriam
Dubucquoi, Sylvain
Classical pathway activity C3c, C4 and C1-inhibitor protein reference intervals determination in EDTA plasma
title Classical pathway activity C3c, C4 and C1-inhibitor protein reference intervals determination in EDTA plasma
title_full Classical pathway activity C3c, C4 and C1-inhibitor protein reference intervals determination in EDTA plasma
title_fullStr Classical pathway activity C3c, C4 and C1-inhibitor protein reference intervals determination in EDTA plasma
title_full_unstemmed Classical pathway activity C3c, C4 and C1-inhibitor protein reference intervals determination in EDTA plasma
title_short Classical pathway activity C3c, C4 and C1-inhibitor protein reference intervals determination in EDTA plasma
title_sort classical pathway activity c3c, c4 and c1-inhibitor protein reference intervals determination in edta plasma
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6784422/
https://www.ncbi.nlm.nih.gov/pubmed/31624460
http://dx.doi.org/10.11613/BM.2019.030707
work_keys_str_mv AT lopezbenjamin classicalpathwayactivityc3cc4andc1inhibitorproteinreferenceintervalsdeterminationinedtaplasma
AT bertiernicolas classicalpathwayactivityc3cc4andc1inhibitorproteinreferenceintervalsdeterminationinedtaplasma
AT ledoultemmanuel classicalpathwayactivityc3cc4andc1inhibitorproteinreferenceintervalsdeterminationinedtaplasma
AT joudinaudromane classicalpathwayactivityc3cc4andc1inhibitorproteinreferenceintervalsdeterminationinedtaplasma
AT maanaouimehdi classicalpathwayactivityc3cc4andc1inhibitorproteinreferenceintervalsdeterminationinedtaplasma
AT majerusvictoria classicalpathwayactivityc3cc4andc1inhibitorproteinreferenceintervalsdeterminationinedtaplasma
AT moitrotemmanuelle classicalpathwayactivityc3cc4andc1inhibitorproteinreferenceintervalsdeterminationinedtaplasma
AT deleplancqueannesophie classicalpathwayactivityc3cc4andc1inhibitorproteinreferenceintervalsdeterminationinedtaplasma
AT rogeaustephanie classicalpathwayactivityc3cc4andc1inhibitorproteinreferenceintervalsdeterminationinedtaplasma
AT launaydavid classicalpathwayactivityc3cc4andc1inhibitorproteinreferenceintervalsdeterminationinedtaplasma
AT lefevreguillaume classicalpathwayactivityc3cc4andc1inhibitorproteinreferenceintervalsdeterminationinedtaplasma
AT labalettemyriam classicalpathwayactivityc3cc4andc1inhibitorproteinreferenceintervalsdeterminationinedtaplasma
AT dubucquoisylvain classicalpathwayactivityc3cc4andc1inhibitorproteinreferenceintervalsdeterminationinedtaplasma